Market Research Blog – Page 15778 – New Product Development

HBsAg Testing Market is set to witness a 5.9% growth during the year 2021-2031

According to the latest research by Future Market Insights, HBsAg Testing market is set to witness a 5.9% growth during the year 2021-2031.

The market has been increasing at a gradual rate and is projected to witness lucrative growth due to increase in cirrhosis and liver cancer deaths due to prevalence of hepatitis B, technological advancements in diagnostic kits and due to increase in cirrhosis and growing awareness regarding early detection of hepatitis B.

What is Driving Demand for HBsAg Testing?

Hepatitis B is a potentially fatal infection and has turned into a vital healthcare problem across the world. Rise in prevalence of hepatitis B and need for early detection of hepatitis B are primary factors supporting the market growth.

In addition, rise in awareness among the population; and increase in initiatives by non-profit organizations and governments add to the development of the market. Increase in awareness among the patients’ leads to early detection of the disease. This is driving the demand for HBsAg testing.

Growing research and innovation, rise in healthcare expenditure and urbanization is resulting into rapid adoption of testing procedures, which in turn leads to market growth.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14155

Rising cases of Hepatitis B, likely to increase the HBsAg Testing Sales

Hepatitis B is an infection of worldwide importance, with a projected of 296 million people living the virus globally, according to the data provided by WHO. In the year 2019, hepatitis led to 820 000 deaths, majorly from complications such as cirrhosis and hepatocellular carcinoma.

The occurrence of hepatitis B is highest in the African and Western Pacific regions where 6.1% and 6.2% respectively of the adults are infected. Hepatitis B can lead to chronic infection and show a high risk of mortality. It is projected that 80-90% of the newborns infected with hepatitis B in first year of life suffer from chronic infections.

There is rise in prevalence of hepatitis B also because of the growing urbanization and environmental changes because of the changing lifestyle. These factors create a lucrative opportunities for hepatitis B diagnostic test manufacturers.

US and Canada HBsAg Testing Market Outlook

United States and Canada lead the HBsAg Testing market. The market is likely to witness significant growth owing to the high prevalence of acute cases of hepatitis B, availability of advanced diagnostic tools and rising awareness regarding hepatitis testing.

The rapid growth in the Canadian market is owing to the initiatives of the non-government and organizations. For example, the Public Health Agency of Canada conducted the World Hepatitis Day with the aim of growing awareness regarding hepatitis diagnosis. Thus, resulting into a demand surge for hepatitis diagnosis in the country.

Europe Demand Outlook for HBsAg Testing

Europe is second lucrative market and is likely to register a remarkable growth owing to the rising cases of hepatitis B infections, increasing diagnostic product launches, and growing healthcare expenditure in the region.

As per the World Health Organization, Hepatitis B is a contagious disease that affected approximately 15 million people in 2019 in the WHO European region. The growing geriatric population is also increasing the demand for hepatitis testing as complications associated with hepatitis worsen with aging.

Who are the Key Manufacturers and Suppliers of HBsAg Testing?

Some of the leading manufacturers and suppliers of HBsAg Testing include

CTK Biotech Inc.
Biopanda Reagents Ltd.
Avecon Healthcare Pvt Ltd.
Abbott
Bio-Rad Laboratories Inc.
Siemens Healthineers
QIAGEN
F. Hoffmann-La Roche AG and others.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14155

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Cognitive Neuroscience Market is set to witness a 4.6% CAGR growth during the year 2021-2031

According to the latest research by Future Market Insights, Cognitive neuroscience market is set to witness a 4.6% CAGR growth during the year 2021-2031. The market has been a moderately competitive market developing at a rapid rate and is anticipated to observe lucrative growth with rising cases of neurological disorders that include Parkinson’s, Alzheimer’s diseases, and other dementias are projected to drive the market growth.

Also, neuroscience-based initiatives by government bodies, high influencing factors, such as current brain mapping research and investigation ventures, and technological advancements in algorithms and tools that are applied in neuroscience space, are anticipated to propel the market growth.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14154

What is Driving Demand for Cognitive Neuroscience?

The rising number of brain-related disorders and the number of advanced healthcare systems are certain driving factors for the market.

Furthermore, key factor that has accelerated the research studies in this arena is the growth in the number of various malignant CNS disorders such as Parkinsonism and Alzheimer’s disease. As geriatric population is prone to various central nervous systems associated disorders such as schizophrenia, Alzheimer’s, and Parkinsonism, with growth in the older population, this market is anticipated to witness lucrative growth.

Also, constant launch of novel products by major participants in the market to fight several neurological disorders is anticipated to increase Y-O-Y growth of this market.

Surge in Number of Deaths Due to Neurological Disorders likely to boost the Cognitive Neuroscience Sales

The rising incidents of neurological disorders, which include Parkinson’s, Alzheimer’s, and other brain-related disorders are expected to encourage participants in the cognitive neuroscience market to help combat such disorders. In 2018, over one hundred thousand people died because of Alzheimer’s in the United States.

Also, rising number of neurological disorder cases are expected to increase the number of deaths occurring due to these disorders. Moreover, the government bodies are growing the medical expenditure to support development of medical facilities in neuroscience leading to development of the market.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14154

US and Canada Cognitive Neuroscience Market Outlook

United States and Canada led the Cognitive Neuroscience market. U.S. Cognitive Neuroscience market is anticipated to witness noteworthy growth owing the existence of neuroscience based research organizations as well as availability of advanced healthcare systems.

Moreover, large organizations and many neuroscientists are spreading knowledge and awareness through programs concerning the brain system in government as well public offices. Also, rise in number of deaths associated with neurological disorders is one of the key factors for the development of the market in U.S.

Europe Demand Outlook for Cognitive Neuroscience

Europe is second leading market and is anticipated to register a significant growth because of the growing burden of neurological diseases in Europe and the availability of large manufacturers in the region.

In 2017, as per ‘The burden of neurological diseases in Europe’ report, over a million deaths occurred in the WHO European region due to neurological diseases. It lead towards a high demand for the growth of the cognitive neuroscience market.

Who are the Key Manufacturers and Suppliers of Cognitive Neuroscience?

Some of the leading manufacturers and suppliers of cognitive neuroscience include

Siemens Healthineers
Scientifica Ltd.
Alpha Omega Inc.
GE Healthcare
Biobserve GmbH
NeuroNexus Technology
Laserglow Technologies
Kendall Research Systems LLC and others.

The cognitive neuroscience market is moderately competitive, with the existence of a large number of players in global markets. Key players in the market are focusing on mergers & acquisitions and partnerships with other small players. Moreover, companies are also concentrating on research activities and new product launches.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/14154

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

More from Healthcare, Pharmaceuticals and Medical devices Market Insights :

Cervical Retractors Market is set to witness robust growth with 6.9% CAGR growth during the year 2021-2031

According to the latest research by Future Market Insights, the cervical reactor market is set to witness robust growth with 6.9% CAGR growth during the year 2021-2031. The rising prevalence of cervical pain, increasing geriatric population and rise in number of cervical spine surgeries across globe are the major factors driving the demand for cervical reactor market.

As to the data released by the United Nations, the world had ~962 million individuals with age 60 or above in 2017, which represented 13 percent of the worldwide population in that year. Further, this population is expected to expand at a pace of 3 percent per year. Spinal problems are the most frequent conditions found in older individuals, affecting 5–55 percent of those with age 55 and above.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14153

What are the Factors Driving the Demand for Cervical Retractors Market?

The growth of the market has been attributed to important factors, including the increasing prevalence age-related cervical conditions, surging geriatric population, increasing adoption of technologically advanced devices, and rise in number of cervical spine surgeries across globe are the major factor driving the demand for cervical retractors.

Furthermore, the key competitors in the market are witnessing the enormous research and development efforts to create new technologically advanced product for non-invasive surgeries.

The U.S. And Canada Cervical Retractors Market Outlook

U.S and Canada are the key manufacture of cervical retractors and the technological advancement for innovative product have encouraged the cervical retractors.?

Factors such as the growing incidents of chronic diseases, rising number of surgical procedures in the region, the presence of a well-established healthcare system, the presence of leading players can be attributed to growth in the U.S. and Canada.

Additionally, U.S. and Canada is the largest contributor to the cervical retractors market, with a similar flow likely to continue and dominate the industry in the next several years.

Europe Demand Outlook for Cervical Retractors Market

Europe’s fastest-growing market for cervical retractors and continues and dominate the industry. Factors such as prevalence of autoimmune disorder, increasing adoption of minimally invasive surgeries, and high R&D focus by major market players are some of the factors driving the cervical retractors market Europe.

Additionally, the growing medical conditions are associated with a high risk for adverse outcomes such as mortality, disability, institutionalization, and hospitalization has also boosted the demand outlook for cervical retractors in Europe.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14153

Who are the Key Manufacturers and Suppliers of Cervical Retractors Market?

Some of the key players operating in the cervical retractors market are

Aesculap
TeDan Surgical Innovations
Life Spine
Thompson Surgical
Medfix International
Rudolf Storz
Globus Medical
Novo Surgical
NSI Health Systems

Companies involve mergers, collaborations, and acquisitions aimed at enhancing their product portfolios, production capacity, and ensuring competitive variety. For instance, In September 2021 a new stand-alone cervical system from Nexxt Spine has been commercially launched. When it comes to titanium’s strength and durability, the NEXXT MATRIXX® Cervical Stand-Alone System matches PEEK’s modulus of elasticity.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/14153

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

More from Healthcare, Pharmaceuticals and Medical devices Market Insights :

Companion Animal Drugs Market anticipated to be worth US$ 52.12 Bn by 2029

During the projected period, the companion animal drugs market is expected to expand at a CAGR of 5%.

The global companion animal drugs market is anticipated to be worth US$ 52.12 Bn by 2029. In 2019, the companion animal drug market was worth US$ 32 Bn. Parasiticides are predicted to continue to be the most popular product, accounting for a third of the market for companion animal drugs. By the end of 2029, North America is predicted to account for 32% of the revenue share in the companion animal drugs industry.

According to the report, increasing focus on pet healthcare is likely to contribute to the build-up of the companion animal drugs market by the end of 2029. Inclination towards compounded drugs to maintain animal health and welfare is expected to increase the sales of companion animal drugs market in 2019 and beyond.

Increasing Urbanization and Growing Affluence in Developing Countries to Benefit the Market

Increasing urbanization level and growing affluence, especially in developing countries, have been driving the adoption of pets, thus leading to increased demand for healthcare products for pets such as companion animal drugs. Continued urbanization has also resulted in increasing prevalence of various diseases such as allergies, lower appetite, reduced energy and behavioral anxieties among small companion animals. This has been driving the demand for innovative classes of medicines such as companion animal drugs.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-1077

Upcoming Therapeutic Innovations in Pet Care to Aid Market Growth

Besides traditional drugs, animal health companies have also been investing in smart diagnostic care to help prevent diseases before the actual onset. Companies are also trying to develop generic capabilities to demonstrate bioequivalence to reference prescription drugs in the companion animal drugs market, as many key drugs no longer benefit from intellectual property protection. The development of new vaccines and medications for animals are expected to support the growth of the companion animal drugs market over the forecast period.

Increasing R&D activities and shorter drug-lifecycle are playing an important role in the growth of the companion animal drugs market. Innovations in companion animal drugs are easier and sustainable for a longer period of time, while R&D cycle time are shorter (~ three years) in the Companion Animal Healthcare (CAH) industry as compared to human health, ranging between seven and 15 years for other drugs. This increases return on investment in companion animal drugs and leads to faster profits for the market players.

Collaborative Ventures to Promote the Companion Animal Drugs Market Growth

Collaborative ventures such as One Health promotes unification of veterinary and medical sciences, leading to better disease surveillance, control and education, especially for companion animals such as dogs and cats. One Health venture enables identification of alteration in infection travelling patterns. The patterns are changing mostly in case of parasites due to change in climate and increasing host-vector interactions. Some organizations helping in monitoring of One Health in companion animals are Companion Animal Parasite Council and European Scientific Counsel Companion Animal Parasites.

Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-1077

Such ventures are expected to complement the growth of the companion animal drugs market.

Low Awareness of Animal Diseases to Hamper the Companion Animal Drugs Market Growth

In many developing countries, people lack awareness regarding certain serious companion animal diseases as opposed to livestock diseases, which are more regularly monitored. This is primarily true with regards to pet vaccinations, which is a mandatory requirement for up to three years. Additionally, parasitic medications for companion animals and livestock are different. Lack of awareness with regards to differentiation of these medication varieties leads to adverse drug side effects and thus low administration of companion animal medications. Such factors are likely to create a hindrance in the growth of the companion animal drugs market.

Also, majority of animal healthcare drugs have limited scope for patent extension, primarily due to drug portfolios dominated by drugs that have crossed maturity, which in turn is expected to deter the growth of the companion animal drugs market over the forecast period.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/1077

Companion Animal Drugs Market Structure Analysis

The global companion animal drugs market is a moderately competitive market. Zoetis, Inc, Elanco (Eli Lily), Merck & Co., Inc., and Merial (Boehringer Ingelheim) are the key players contributing maximum revenue share to the market.
Expansion of the business through mergers, acquisitions, collaborations, and alliances are the strategies followed by key players in the companion animal drugs market. Key market players focus on strategies such as development of new medications and introducing them into the market for evolving infectious diseases.
Noteworthy investments in the research and development for novel drugs are projected to boost the growth prospects of the companion animal drugs market.
Global and local market players are benefiting from a significant marketing network of distributors. Also, online veterinary pharmacy services are contributing to the growth of the companion animal drugs market.

Negative Pressure Wound Therapy (NPWT) Market reaching a valuation of US$ 3.2 Bn by 2029.

Effectiveness of negative pressure wound therapy (NPWT) in treating acute and chronic wounds is a key factor driving its adoption across hospitals, clinics, and homecare settings. The use of NPWT devices in managing closed incisions, where the risk of wound breakdown is higher, is also fuelling the growth of the negative pressure wound therapy market, especially in North America and Western Europe.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-810

Development of safe and highly-effective negative pressure wound therapy devices has helped address concerns related to potential risks, leading to greater adoption across end-use sectors. Decline in the number of adverse reaction and product recalls has led to increased confidence on the safe use of NWPT.

FMI-a well-established name in the market research domain – forecasts that, the NPWT market will experience a major upturn post 2025, reaching a valuation of US$ 3.2 Bn by 2029.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-810

Key Takeaways of NPWT Market Study

Single-use disposable negative pressure wound therapy devices, under product, are expected to exhibit a CAGR of 8% during the forecast period.
The U.S. is anticipated to dominate the global negative pressure wound therapy market and account for over 86% share of the North America NPWT market.
Hospitals and home care settings segments are expected to dominate the negative pressure wound therapy market during the forecast period, owing to significant adoption of NPWT systems.
Companies are focusing on collaborating with established research centres and other manufacturers to develop products complaint with regulations across the globe that can help in the treatment of chronic disorders.

“Increasing awareness among practitioners and patients about the better response rate of disposable negative pressure wound therapy devices is expected to increase revenue of the NPWT market over the coming years.”

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-810

Manufacturer of NPWT Devices Focusing on Launch of Portable and Disposable Devices

Over the last few years, leading manufacturer have been focusing on introducing portable and disposable NPWT devices, targeting a range of consumers, including hospitals, homecare settings, etc. Presently, a majority of NPWT devices are used in the U.S. and Europe. However, the demand for portable and disposable NPWT devices is gaining traction in APAC, Eastern Europe, and Latin America. There has been growing interest in using portable and disposable NPWT devices on closed incisions after a surgical procedure in order to inhibit potential surgical site infections (SSIs) and other wound complications in high-risk patients.

Examples of some disposable NPWT devices from top players include the V.A.C.Via Therapy System, Prevena Incision Management System (Acelity), PICO (Smith and Nephew PLC.), AVELLE Negative Pressure Wound Therapy System (ConvaTec Inc.)

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Arthroscopy Procedure and Products Market is set to expand at 5.7% CAGR through 2023

The global arthroscopy procedures and products market is set to expand at 5.7% CAGR through 2023, Arthroscopy devices are rapidly adopted to examine the bone joints for specific conditions, such as osteoarthritis, rheumatoid arthritis, tendinitis, and bone tumor. The surgeons, during the surgery, insert a narrow tube which is attached to a fiber-optic video camera through a small incision.

The global minimally invasive surgery devices market is forecast to surpass US$ 30 Bn by 2018, and the growth is expected to rub off on the arthroscopy market. Increasing application in sports medicine, demographic trends, rising prevalence of osteoarthritis and ease in FDA clearance are key factors driving growth of the global arthroscopy procedures and products market. On the other hand, risk of edema due to irrigation fluids and increasing pricing pressures are anticipated to hamper market growth during the forecast period.

Request a Sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1386

Arthroscopy Procedures and Products Market Segmentation

By product type, the global arthroscopy procedures and products market is segmented into arthroscopes and visualisation systems, arthroscopic resection systems, arthroscopic fluid management systems, arthroscopic implants, arthroscopy radiofrequency (RF) systems, arthroscopic drills and fixation systems and other arthroscopy instruments and accessories.

The arthroscopic implants segment is further sub-segmented into knee implants, shoulder implants, hip implants and other implants. The arthroscopic implants product type segment accounts for highest share of the arthroscopy procedures and products market currently, and is expected to remain the leading segment in terms of value during the forecast period. Increase in clinical evidences related to the safety, efficacy and economic benefits of arthroscopic implants in younger patients is expected to boost growth of arthroscopic implants segment during the forecast period.

Preview Analysis: https://www.futuremarketinsights.com/ask-question/rep-gb-1386

By procedure type, the knee arthroscopy segment is expected to hold more than half the global market share, and the revenue from the segment is projected to expand at the highest CAGR over the forecast period as compared to other segments.

By region, North America is the largest market in terms of value currently and is expected to retain its position through the forecast period. Increasing number of ambulatory surgical centres, developing techniques and equipment, and increasing usages of arthroscopic instruments used in hips, shoulders, ankles and wrists procedures are factors expected to boost growth of the North America market over the forecast period.

Markets in the Americas and Europe collectively accounted for over 75% revenue share of the global arthroscopy procedures and products market in 2015. The market in APAC region is projected to exhibit an above average CAGR in terms of value during the forecast period from 2015 to 2023. Increase in preference of arthroscopic surgeries and technological advancement in arthroscopic instruments are factors expected to fuel demand for arthroscopy products over the forecast period.

Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1386

Key market players covered in this report are Arthrex, Inc., CONMED Corporation, Johnson & Johnson, KARL STORZ GmbH & Co. KG, Olympus Corporation, Richard Wolf GmbH and Stryker Corporation. Collaboration with partners to maintain market leadership in sports medicine in different regions, engaging in R&D activities that focus on orthopaedic surgical treatments, leveraging core expertise to strengthen business plans and acquisitions to strengthen the arthroscopy manufacturing business units in order to enhance market foothold over the next four to five years are the key strategies adopted by the arthroscopy products manufacturers.

FMI Latest Insights:

General Anesthesia Drugs Market: http://www.futuremarketinsights.com/reports/general-anesthesia-drugs-market

Respiratory Inhaler Market: http://www.futuremarketinsights.com/reports/respiratory-inhaler-devices-market

Ophthalmic Diagnostic Equipment Market: http://www.futuremarketinsights.com/reports/ophthalmic-diagnostic-equipment-market

About Future Market Insights (FMI)

Respiratory Inhaler Devices Market 2022 Strategic Analysis, Growth Drivers, Industry Trends, Demand And Future Opportunities Till 2031

The rising prevalence of respiratory disorders has necessitated innovation in manufacture of respiratory inhalers. The demand for better precision in drug delivery is enabling broader adoption of Respiratory Inhaler Devices, especially among patients of asthma and chronic obstructive pulmonary diseases (COPD). Steady growth is expected to continue as favorable reimbursement policies by governments create a conducive environment around the world.

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for respiratory inhalers. The report tracks the global sales of respiratory inhalers in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the medical device industry in general, and Respiratory Inhaler Devices in particular.

For instance, Sustainable Development Goals (SDG) created by the United Nations in 2016 were intended at improving living standard globally. Likewise, the Forum of International Respiratory Societies (FIRS) was a part of a worldwide call for action to address the soaring burdens of respiratory diseases. These efforts have been crucial in driving demand for respiratory inhalers. According to FMI’s analysis, respiratory inhaler sales have grown at 3.4% CAGR between 2015 and 2019.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-493

A slew of new drugs were launched for the management of asthma and COPD over the last decade and development of more are currently underway. With leading drug manufacturers expecting the demand to surge amid COVID-19, respiratory inhaler sales are set to grow steadily through 2030.

The pandemic crisis has resulted in the fast-tracking of drug approval, a trend most welcome by drug manufacturers. In a statement the U.S. Food and Drug Administration (USFDA) has recognized the surging demand for albuterol products amid pandemic crisis. The organization also reiterated its commitment to facilitating access to medical products in the statement. These developments present a positive outlook for growth. FMI expects global respiratory inhalers market to grow at 4.4% CAGR through 2030.

Global demand for respiratory inhaler devices continues to be driven by rising prevalence of COPD and asthma. According to the World Health Organization (WHO), nearly 251 million cases of chronic obstructive pulmonary disease (COPD) were reported worldwide in 2016 and nearly 339 million people were estimated to have asthma in the same year. Coupled with this, surging healthcare spending has been creating lucrative prospects for growth of the market.

Market players also are focusing on novel inhalation technologies to ascertain drug delivery to lungs. Spurred by these factors, the global market for respiratory inhaler devices is expected to report surging sales.

Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-493

Smart Inhaler Technology Touted as a Major Breakthrough

Smart inhalers have been touted as a disruptive technology, and it remains a key focus area for manufacturers. Smart inhalers can signal patients if their overusing any medication, warning them against poor management of the condition. The technology is touted as a major breakthrough in the healthcare sector and one that is expected to enable growth in the respiratory inhaler devices market in the coming years.

Several studies already are underway gauging the potential of these development. For instance, My AirCoach, which is an EU-funded multi-institutional research project, aims at assessing how novel mobile health technologies, including smart inhalers, can help offering improved asthma control.

With myriad of developments underway, respiratory inhaler device shipments are likely to gain traction through 2030. FMI’s report offers a comprehensive analysis on how growth will unfold. Some of the key takeaways from the report are:

Dry powder inhalers remain the most lucrative category
Manually operated inhaler devices will remain preferred choice among available technologies
Respiratory inhaler devices sales surging to offer improved asthma control and management
US to remain a highly lucrative market for respiratory inhaler devices, however, growth in East Asia is expected to accelerate at a higher pace

“Some of the leading players are working on technologies that would enable monitoring and correction of inhalation techniques in the near future. They are developing smart inhalers that will use the Bluetooth technology to monitor inhaler use in patients. While several developments are underway, industry experts are cautiously examining the potential of smart inhalers to ensure all potential concerns pertaining to the novel technologies are ironed out. However once launched, smart technology can help the market gain momentum at accelerated pace in the near future,” said a lead analyst at FMI.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/493

Who is winning?

Some of the leading companies are focusing on innovations and product launches to gain competitive advantage. There also are companies trying to capitalize on opportunities across high potential markets. For instance, Zydus Cadila has announced launching India’s first pressurized Metered Dose Inhaler (pMDI) – Forglyn pMDI with a combination of Long Acting Beta Agonist (LABA) and Long Acting Muscarinic Antagonist (LAMA) for COPD patients in October 2020.

In 2019, Lupin announced launching “ADHERO,” which is a connected smart device for metered dose inhalers and promises to ensure improved adherence to inhalation therapy for COPD treatment.

Europe Viscosupplementation Market is projected to register healthy CAGR of 5.1% during 2016-2026

Future Market Insights (FMI) delivers key insights on the Europe viscosupplementation market in its upcoming report titled, “Viscosupplementation Market: Europe Industry Analysis and Opportunity Assessment, 2016-2026”. In terms of revenue, the Europe viscosupplementation market is projected to register a healthy CAGR of 5.1% during 2016-2026.

FMI’s report has segmented the market on the basis of product type, end user and region.

Based on product type, the market has been segmented into one injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation.

Single injection viscosupplementation product type segment is expected to emerge as the most popular segment over the forecast period, driven by better patient compliance as the treatment reduces the need for multiple hospital visits. The segment is expected to register the highest CAGR of 6.7% during the forecast period.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-eu-1383

Five injection viscosupplementation product type segment is expected to witness a decline in market share in terms of revenue from 29.0% in 2015 to 23.3% in 2026. This decline is attributed to more incidence of side effects and repeated patient visit requirements associated with five injection viscosupplementation. Reimbursement cutbacks and high injection costs are other factors that can curtail demand for five injection viscosupplementation.

By end-users, the market is segmented into hospitals, ambulatory surgical centres and orthopaedic clinics. Hospitals end-use segment is expected to witness significant demand for viscosupplementation, registering a CAGR of 4.3% over the forecast period. Better reimbursement options and increasing patient preference for single injection cycle for osteoarthritis treatment is expected to drive demand for one injection viscosupplementation in the orthopaedic clinics segment over the forecast period.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-eu-1383

Europe Viscosupplementation Market Trends

Key trends in the viscosupplementation market are the use of single injection cycle for osteoarthritis treatment and introduction of new combination products in the market. For example, the product pipeline of major players in the viscosupplementation market involves combining corticosteroid injections, which help in relieving pain associated with osteoarthritis, with long-lasting effects of hyaluronic acid, which lasts for nearly six months. Further, regional competition within EU countries, especially in five injection cycle, is leading to entry of new market players. Europe is a mature market in terms of generic products and it is therefore relatively easier to obtain CE mark in Europe than it is to obtain the U.S. FDA approval.

Western Europe has been estimated to dominate the Europe viscosupplementation market in 2015, attributed to factors such as the presence of key regional players, strong distribution network and better healthcare infrastructure in the region.

Query Discussion With Analyst@ http://www.futuremarketinsights.com/askus/rep-eu-1383

Key Players in Europe Viscosupplementation Market

Some key players in the Europe viscosupplementation market are Anika Therapeutics Inc., Sanofi S.A., Zimmer Biomet Holdings, Meda AB, Ferring B.V, Fidia Pharmaceutici S.p.A, and Bioventus LLC. We have discussed individual strategies followed by these companies in terms of enhancing product designs, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways that could help players already present in the market and new players planning to enter the market in the long run.

About Future Market Insights (FMI)

Connected Healthcare Market is set to experience 15.6% growth during year 2021-2031

According to the latest research by Future Market Insights, Connected healthcare market is set to experience 15.6% growth during the year 2021-2031. Due to need for effective communication.

What is driving Demand for Connected healthcare market?

Growth in the incidence rate of injuries in all age groups is one of the major factors driving the growth of connected healthcare market. Various activities such as trekking and adventure sports further results in abrasion, minor injuries, multiple cuts and wounds on different body parts. In such cases, elastic bandages are use while the treatment procedure takes place.

Moreover, rising count of road accidents has increased significantly worldwide. These accidents can be considered as fatal or non-fatal injury, some of these non-fatal injuries require speedy application of bandages in order to stop any further damage

For instance, according to Stanford children’s health approx. number of around 3.5 million children’s of around 14 years and below get injured while playing sports or doing any adventurous activity

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14107

Elastic Bandages used for upper limbs and lowers is likely to augment connected healthcare market.

For lower limbs, the elastic bandages are used for the treatment of hairline fracture, joint dislocation, cure factures, ankle sprains, orthopaedic procedures, varicose veins, deep cuts, accidental amputations, thigh cramps and muscle pulls. Bandages for lower limbs are majorly used by the athletes and its sales in the market is quite significant during sports season such as Olympics, national games and international games.

For the purpose of upper limbs, bandages are used widely for the treatment of hairline fractures, joint dislocation, acute injuries and swelling, it further offers support to injured soft tissues. They are widely used in cases of elbow figure eight, hand wrist figure eight along with compression dressings.

U.S. and Canada Connected healthcare market Outlook

U.S. and Canada are expected to have the highest share and therefore will dominate the connected healthcare market. This is due to the increasing orthopaedic injuries, upward trend growth rate in the surgeries and prevalence of chronic wounds are further resulting in the growing usage of elastic bandages along with medical tapes in this region.

Europe Demand Outlook for Veterinary Home Diagnostics

The European market for veterinary home diagnostics is estimated to grow at a considerable rate during the forecast period. This surge in growth is due rising geriatric population with venous diseases in this region. Th growing prevalence of deep vein thrombosis, lymphedema and chronic leg ulcers has further significantly increased the use of elastic bands in this region

Moreover, the presence of various key players in this region along with easy availability of elastic bandages is contributing positively towards the market growth. Furthermore, rising awareness of compression therapy, along with the increasing usages of elastic bandages and expansion of various key players in this region uplifts the market growth of elastic bandages in this region.

Who are the Key Manufacturers and Suppliers of Veterinary Home Diagnostics?

Some of the key players operating in the Connected healthcare market are

3M
CardinalHealth
Avcor Health Care
Tetra Medical Supply Corp
Patterson Medical
DJO Global
Paul Hartmann
Medtronic

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14107

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

About Future Market Insights (FMI)

Microparticle Injectables Market are set to witness a steady-paced growth of CAGR 5.8% during the year 2021-2031

According to the latest research by FMI, Microparticle Injectables are set to witness a steady-paced growth of CAGR 5.8% during the year 2021-2031. Microparticle Injectables are broadly used constituents of multi-particulate drug delivery systems, offering both technological and therapeutic advantages. The Global Microparticle Injectables market study provides critical information related to the global, regional and top players including Microparticle Injectables market share analysis, winning strategies, recent developments, and financial planning. Besides providing information regarding the key players in the Microparticle Injectables market, the study also recalibrates, the impact of macroeconomic and microeconomic factors that has the potential to impact the growth of the Microparticle Injectables market.

Over the past decade, healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics.

Understanding the Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

The FMI’s latest report on the Microparticle Injectables market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic.

Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14106

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Competitive Analysis

By Prominent Market Players

Lubrizol Life Science
Baxter International Inc
Sandoz
Eli Lilly and Company
Pfizer Inc.
Evonik
Oakwood Labs and GP Pharm.

With an extensive SWOT analysis, the FMI’s study presents the strengths, weaknesses, growth prospects and challenges of each player. The report also includes important data including the sales strategy, pricing strategy, and marketing strategy adopted by these players in the Microparticle Injectables market

Any Queries About Report, Contact Us @ https://www.futuremarketinsights.com/askus/rep-gb- 14106

Microparticle Injectables Market: Segmentation

By Therapeutic Application:

Chronic Diseases
Autoimmune Diseases
Hormone Related Disorders
Oncology
Others

By Administration Site:

Central Nervous System
Skin
Musculoskeletal
Targeted Organs

By Distribution Channel:

Medical Hospital Pharmacy
Retail Pharmacy

By Region:

North America
Latin America
Europe
South Asia
East Asia
Middle East and Africa

Request For Table of Content @ https://www.futuremarketinsights.com/toc/rep-gb- 14106

Critical Questions Answered in the Report

What are ongoing trends that will shape market growth curve for global Microparticle Injectables market?
What are the drivers and challenges affecting the Microparticle Injectables market demand?
What are the recent technological advancement in the Microparticle Injectables market?
What are key trends and opportunities that will prevail the revenue growth of Microparticle Injectables market players?
How will evolving regulatory policies impact the market growth?
What is the impact of Covid-19 on the Microparticle Injectables market?

About Future Market Insights (FMI)